On February 1, 2013, Labtec GmbH begins operating under the new name
Labtec GmbH. The global tesa
Group integrates development and production of transdermal patches and
fast-dissolving oral films under one roof.
"key visual": "Solutions for Pharma - tesa Labtec GmbH" (Photo: Business Wire)
tesa SE (3,800 employees, 53 affiliates), one of the world's leading
providers of adhesive tapes and selfadhesive system solutions for
industry, trade and consumers, acquired Labtec GmbH at the end of 2008
as a wholly owned affiliate. Founded in 1990, the company specializes in
developing transdermal patches (Transfilm®) and fast-dissolving oral
Concurrently, the technology group invested around EUR 18 million in a
clean room unit at the tesa plant in Hamburg-Hausbruch accommodating a
6000 square meters, state-of-the-art pharmaceutical production facility.
The site is one of the most modern in Europe and covers every aspect of
pharmaceutical development and production processes including adhesive
mixing and compounding, coating, converting, and packaging. The
regulatory approval to manufacture pharmaceutical products was obtained
in March 2011, and since then numerous clinical trial products were
manufactured. Development capacity was doubled which proved to be
crucial for the successful expansion of partnerships with
internationally renowned pharmaceutical companies, both from the branded
and generic sectors.
Effective February 1, the pharmaceuticals unit of tesa Werk Hamburg
GmbH, Labtec GmbH, and the pharma business unit at tesa SE have been
consolidated to form the new tesa Labtec GmbH. The tesa affiliate's
operating units continue to be located in Hamburg and Langenfeld.
"Closely integrating our competencies in this way puts us in an even
better position to offer customers a one-stop shop for all their needs,"
says Managing Director Ingo Lehrke. "We are already experiencing
significant interest from industry, especially in our high-efficiency
production capacities." Lehrke is joined by fellow Managing Directors
Joachim Suesse and Dr. Heinrich Koch.
"Solutions for Pharma": tesa Labtec GmbH launches its new key visual and
Internet presence (www.tesa-labtec.com)
on February 1.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130131006234/en/
[ Back To NFVZone's Homepage ]